CLINICAL_TRIALS
trial_result
· 2020-03-12
Clinical Trial Update: A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers [Phase 1]
Summary
Phase 1 bioequivalence study of two nicotine lozenges in fasting healthy smokers completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Tobacco Use Disorder | Phase 1 | Status: COMPLETED | Results posted: 2020-03-12